Maplebrook GP, LLC is a real estate fund based in Orange Village. According to its most recent Form D, filed Dec 30, 2021, it has sold $1,750,000 of interests to 20 investors since its first sale in Dec 2021. The minimum investment it accepts from an outside investor is $10,000. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Paul Kiebler, IV.
- Total raised
- $1,750,000Cumulative sales reported on Form D
- Investors
- 20
- First sale
- Dec 15, 2021
- Minimum investment
- $10,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Paul Kiebler, IV
- Latest Form D
- Dec 30, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Maplebrook GP, LLC
What is the minimum investment for Maplebrook GP, LLC?
According to its latest Form D, filed Dec 30, 2021, the minimum investment Maplebrook GP, LLC accepts from an outside investor is $10,000.
Who can invest in Maplebrook GP, LLC?
Maplebrook GP, LLC is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Maplebrook GP, LLC raised?
Maplebrook GP, LLC reports $1,750,000 sold from 20 investors on its Form D filed Dec 30, 2021. This is cumulative sales since the offering began, not current assets or performance.
Where is Maplebrook GP, LLC based?
Maplebrook GP, LLC is based in Orange Village.
When did Maplebrook GP, LLC launch?
Maplebrook GP, LLC reports its first sale in Dec 2021.